Tata Institute Claims Its Rs 100/ Tablet Can Prevent Cancer Recurrence - moneycontrol
Tata Institute claims it has developed a tablet that could prevent cancer from recurring and reduce the side effects of treatment by 50%. The tablet, which c...
Tata Institute claims it has developed a tablet that could prevent cancer from recurring and reduce the side effects of treatment by 50%. The tablet, which c...